Publication | Closed Access

Anti-tumoral effect of active immunotherapy in C57BL/6 mice using a recombinant human VEGF protein as antigen and three chemically unrelated adjuvants

Cancer ImmunosurveillanceActive ImmunotherapyMedicineAnti-tumoral EffectImmunologyTherapeutic VaccineImmune Checkpoint InhibitorImmunomodulationCell TransplantationC57bl/6 MiceImmunotherapyOncologyRadiation OncologyTumor MicroenvironmentCancer Research